Exactly. Since we have been delayed with numerous launches/PR's, 2013 is shaping up to be a busy year for Elite. Not even mentioning the idea of Lodrane coming back and the BE trial data. We will have a lot to talk about. =)
(0)
(0)
Elite Pharmaceuticals Inc (ELTP) Stock Research Links
